References
- JakubusTMichalska-JakubusMLukawskiKAtherosclerotic risk among children taking antiepileptic drugsPharmacol Rep20096141142319605940
- MintzerSSkidmoreCAbidinCEffects of antiepileptic drugs on lipids, homocysteine, and C-reactive proteinAnn Neurol20096544845619296463
- AslanKBozdemirHUnsalCGuvencBThe effect of antiepileptic drugs on vitamin B12 metabolismInt J Lab Hematol200730263518190464
- KaplanEDAssociation between homocyst(e)ine levels and risk of vascular eventsDrugs Today (Barc)20033917519212730702
- NarayanasamyASubramaniamBKarunakaranCHyperhomocysteinemia and low methionine stress are risk factors for central retinal venous occlusion in an Indian populationInvest Ophthalmol Vis Sci2007481441144617389469
- MarcucciRBertiniLGiustiBThrombophilic risk factors in patients with central retinal vein occlusionThromb Haemost20018677277611583306
- LaheyMTunçMKearneyJLaboratory evaluation of hypercoagulable states in patients with central retinal vein occlusion who are less than 56 years of ageOphthalmology200210912613111772591
- MoghimiSNajmiZFaghihiHHyperhomocysteinemia and central retinal vein occlusion in Iranian populationInt Ophthalmol200828232817636432
- GaoWWangYZhangPWangHHyperhomocysteinemia and low plasma folate as risk factors for central retinal vein occlusion: a case–control study in a Chinese populationGraefes Arch Clin Exp Ophthalmol20062441246124916538453
- SalaunNDelyferM-NRougierM-BKorobelnikJ-FÉvaluation du bilan étiologique des occlusions veineuses rétiniennes du sujet âgé de moins de 60 ansJ Fr Ophtalmol20073091892318046276
- WegerMStangerODeutschmannHHyperhomocyst(e)inemia, but not methylenetetrahydrofolate reductase C677T mutation, as a risk factor in branch retinal vein occlusionOphthalmology20021091105111912045051
- WaldDSLawMMorrisJKThe dose-response relation between serum homocysteine and cardiovascular disease: implications for treatment and screeningEur J Cardiovasc Prev Rehabil20041125025315179109